IPSEF News and Press, Ipsen Sa Ord From 01/09/23

Transaction focused on Bylvay ® (odevixibat), the first-approved treatment in progressive familial intrahepatic cholestasis in U.S. and E.U., with potential in other rare diseases Acquisition aligned with Ipsen’s long-term strategy for expanding the scope of its Rare Disease p...

The CRL is related to the U.S. FDA’s previous request for additional information on palovarotene clinical trial data Ipsen anticipates responding to the request in the first quarter of 2023 Regulatory News: The U.S. Food and Drug Administration (FDA) issued a Complete Res...

The trial did not meet its primary endpoint of overall survival (OS) The safety profile of the combination of cabozantinib and atezolizumab was consistent with the known safety profiles for each single agent The clinical trial results will be presented at a future medical meeting ...

The following slide deck was published by Ipsen S.A. in conjunction with their 2022 Q3 earnings call. For further details see: Ipsen S.A. 2022 Q3 - Results - Earnings Call Presentation

Ipsen S.A. (IPSEY) Q2 2022 Earnings Conference Call July 28, 2022 7:30 AM ET Company Participants David Loew – Chief Executive Officer Aymeric Le Chatelier – Chief Financial Officer Howard Mayer – Head of Research and Development Confer...

The following slide deck was published by Ipsen S.A. in conjunction with their 2022 Q2 earnings call. For further details see: Ipsen S.A. 2022 Q2 - Results - Earnings Call Presentation

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Epizyme (NASDAQ: EPZM ) stock is up nearly 65% today on news that the biotechnology company is going to be acquired by French pharmaceutical concern Ipsen (OTCMKTS: IPSEF ). A joint news release by the compani...

The clinical-stage oncology company Fusion Pharmaceuticals ( NASDAQ: FUSN ) announced on Thursday that the FDA cleared its Investigational New Drug (IND) applications for [225Ac]-FPI-2059 and the corresponding imaging analogue [111In]-FPI-2058. FPI-2059 is a small molecule...

The following slide deck was published by Ipsen S.A. in conjunction with their 2021 Q4 earnings call. For further details see: Ipsen S.A. 2021 Q4 - Results - Earnings Call Presentation

Ipsen S.A. (IPSEY) Q4 2021 Earnings Conference Call February 11, 2022, 8:00 AM ET Company Participants David Loew – Chief Executive Officer Aymeric Le Chatelier – Group Chief Financial Officer Howard Mayer – Head of Research and Development Conference Call Participants Je...